AU3705695A - Pharmaceutical composition comprising atovaquone - Google Patents

Pharmaceutical composition comprising atovaquone

Info

Publication number
AU3705695A
AU3705695A AU37056/95A AU3705695A AU3705695A AU 3705695 A AU3705695 A AU 3705695A AU 37056/95 A AU37056/95 A AU 37056/95A AU 3705695 A AU3705695 A AU 3705695A AU 3705695 A AU3705695 A AU 3705695A
Authority
AU
Australia
Prior art keywords
atovaquone
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37056/95A
Inventor
Craig William Davis
Walker Anderson Long
Kevin Alexander Miller
Jeffrey Scott Staton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of AU3705695A publication Critical patent/AU3705695A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU37056/95A 1994-10-26 1995-10-25 Pharmaceutical composition comprising atovaquone Abandoned AU3705695A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9421585 1994-10-26
GB9421585 1994-10-26
PCT/GB1995/002523 WO1996013254A1 (en) 1994-10-26 1995-10-25 Pharmaceutical composition comprising atovaquone

Publications (1)

Publication Number Publication Date
AU3705695A true AU3705695A (en) 1996-05-23

Family

ID=10763436

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37056/95A Abandoned AU3705695A (en) 1994-10-26 1995-10-25 Pharmaceutical composition comprising atovaquone

Country Status (2)

Country Link
AU (1) AU3705695A (en)
WO (1) WO1996013254A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2159938T3 (en) * 1997-02-11 2001-10-16 Mse Pharmazeutika Gmbh TRANSDERMIC, ORAL AND INTRAVENOUS PREPARATIONS OF 2,3-DIMETOXI-5-METHYL-6-DECAPRENIL-1,4-BENZOQUINONA.
DE10347994A1 (en) 2003-10-15 2005-06-16 Pari GmbH Spezialisten für effektive Inhalation Aqueous aerosol preparation
EP1712220A1 (en) * 2005-04-15 2006-10-18 PARI GmbH Spezialisten für effektive Inhalation Pharmaceutical aerosol composition
EA016072B1 (en) * 2005-05-18 2012-01-30 Палметрикс Инк. Use of calcium salt formulation for alteration of biophysical properties of mucosal lining
CN109640948B (en) * 2016-06-16 2023-05-02 利物浦大学 Chemical composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0362996B1 (en) * 1988-08-16 1994-04-27 The Wellcome Foundation Limited Naphthoquinones for the treatment and prophylaxis of pneumocystis carinii infections
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
AU1299095A (en) * 1993-12-02 1995-06-19 Cytrx Corporation Antiinfective compositions and methods of use

Also Published As

Publication number Publication date
WO1996013254A1 (en) 1996-05-09

Similar Documents

Publication Publication Date Title
AU3532195A (en) Medicaments
AUPN411195A0 (en) Medicinal composition
AU5136998A (en) Medicinal composition
AU3308195A (en) Antihypertriglyceridemic composition
AU2630295A (en) 2-acylaminopropanol compound and medical composition
AU5155096A (en) Pharmaceutical composition
AU2531295A (en) Pharmaceutical composition
AU1475595A (en) Pharmaceutical preparation
AU3705695A (en) Pharmaceutical composition comprising atovaquone
AU1544195A (en) Pharmaceutical compositions
AU1427895A (en) Pharmaceutical compositions
AU2813195A (en) Composition
AU6814496A (en) Pharmaceutical composition
AU3885995A (en) Novel medicinal use
AUPM841894A0 (en) Pharmaceutical composition
AUPM341094A0 (en) Pharmaceutical composition
AUPN007494A0 (en) Pharmaceutical composition
AUPM675994A0 (en) Medicinal composition
AU3291295A (en) Composition
AUPM938594A0 (en) Smokehood 173
AU723097C (en) Pharmaceutical composition
AU741226C (en) Pharmaceutical composition
AUPN927496A0 (en) Pharmaceutical composition
AUPN890796A0 (en) Pharmaceutical composition
AUPN876196A0 (en) Medicinal composition